You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES
  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    Keep life flowing

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  1. 1
  2. 2
  3. 3

News

CORPORATE

Kedrion’s Mother and Child Health campaign for Asia and MEA announced

Details were unveiled during our first televised Regional Distributor Meeting on July 14th-15th

read more 

CORPORATE

COVID-19. Kedrion partners with Columbia University Irving MC

Kedrion and Columbia University release video statements

read more 

EVENTS

ISTH, Kedrion supports symposium on the importance of inhibitor eradication

The central theme of the round table will be the optimization of the treatment of patients with Hemophilia A

read more 

2019
ANNUAL REPORT

Kedrion hilite image
Kedrion hilite image
Kedrion hilite image

OPEN INNOVATION